{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Statins May Not Affect Memory, Study Suggests", "kicker": "Well", "print_headline": "Behavior: Good News About Statins"}, "abstract": "New research indicates that the association between memory loss and statin use may be an illusion.", "print_page": null, "word_count": "223", "_id": "5579595e7988104410e6e8b5", "snippet": "New research indicates that the association between memory loss and statin use may be an illusion.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2015/06/11/statins-may-not-affect-memory-study-suggests/", "multimedia": [{"subtype": "wide", "url": "images/2012/06/19/health/well_behavior/well_behavior-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2012/06/19/health/well_behavior/well_behavior-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/06/19/health/well_behavior/well_behavior-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/06/19/health/well_behavior/well_behavior-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "false", "keywords": [{"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Memory", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "JAMA Internal Medicine (Journal)", "is_major": "Y", "rank": "3", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "blogpost", "pub_date": "2015-06-11T05:45:25Z", "section_name": "false"}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "Death Without Dignity", "kicker": "The End", "print_headline": "Death Without Dignity"}, "abstract": "When my friend wanted to end her life, an aid-in-dying law could have helped.", "print_page": null, "word_count": "905", "_id": "5577e5dc798810054cfd03df", "snippet": "When my friend wanted to end her life, an aid-in-dying law could have helped.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2015/06/10/death-without-dignity/", "multimedia": [{"subtype": "wide", "url": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-articleLarge.jpg", "height": 342, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-articleLarge.jpg", "xlargeheight": "342"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Death and Dying", "name": "subject", "rank": "1"}, {"value": "Law and Legislation", "name": "subject", "rank": "2"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Annabelle", "lastname": "GURWITCH"}], "original": "By ANNABELLE GURWITCH"}, "document_type": "blogpost", "pub_date": "2015-06-10T03:21:36Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease, the biggest killer of Americans.", "headline": {"main": "Federal Panel Backs Approval of New Drug to Fight Heart Attacks", "print_headline": "Drug to Fight Heart Attack Clears Panel "}, "abstract": "Expert panel recommends Food and Drug Admin approve strong new drug to protect against heart attacks; it would be first in new group of medicines that substantially lower levels of cholesterol, leading cause of heart disease; drugs are made by Sanofi, Regeneron Pharmaceuticals and Amgen.", "print_page": "1", "word_count": "1306", "_id": "5577160f798810054cfd0199", "snippet": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease, the biggest killer of Americans.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/06/10/health/cholesterol-levels-ldl-drugs-heart-attacks-fda-panel.html", "multimedia": [{"subtype": "wide", "url": "images/2015/06/10/us/DRUGS/DRUGS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/06/10/us/DRUGS/DRUGS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/06/10/us/DRUGS/DRUGS-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/06/10/us/DRUGS/DRUGS-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/06/10/us/DRUGS/DRUGS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/06/10/us/DRUGS/DRUGS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Heart", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Cholesterol", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Amgen Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Sanofi SA", "is_major": "Y", "rank": "5", "name": "organizations"}, {"value": "Regeneron Pharmaceuticals Inc", "is_major": "Y", "rank": "6", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "7", "name": "organizations"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2015-06-10T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Since retiring from the U.S. Army in 2000, Dr. John Henry Hagmann has helped train thousands of soldiers and medical personnel in how to treat battlefield wounds. His company, Deployment Medicine International, has received more than $10.5 million in business from the federal government.", "headline": {"main": "Exclusive: Doctor Who Trained U.S. Troops Suspended for Macabre Techniques", "print_headline": "Exclusive: Doctor Who Trained U.S. Troops Suspended for Macabre Techniques"}, "abstract": null, "print_page": null, "word_count": "1633", "_id": "5576021679881065a6aa431b", "snippet": "Since retiring from the U.S. Army in 2000, Dr. John Henry Hagmann has helped train thousands of soldiers and medical personnel in how to treat battlefield wounds. His company, Deployment Medicine International, has received more than $10.5 million in...", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2015/06/08/us/08reuters-usa-doctor-probe.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2015-06-08T16:55:55Z", "section_name": "U.S."}], "meta": {"hits": 4, "offset": 0, "time": 35}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}